share_log

Harrow Health Analyst Ratings

Harrow Health Analyst Ratings

哈罗健康分析师评级
Benzinga ·  2023/07/20 22:21
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/20/2023 106.99% B. Riley Securities $42 → $45 Maintains Buy
04/17/2023 70.19% Lake Street $24 → $37 Maintains Buy
09/08/2022 -21.8% B. Riley Securities → $17 Reinstates → Buy
05/20/2022 -8% B. Riley Securities $17 → $20 Maintains Buy
07/02/2021 -34.45% Ladenburg Thalmann → $14.25 Initiates Coverage On → Buy
04/07/2020 -54% B. Riley Securities $12 → $10 Maintains Buy
03/16/2020 -44.8% B. Riley Securities $12.75 → $12 Maintains Buy
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
07/20/2023 106.99% B. 莱利证券 42 美元 → 45 美元 维护 购买
04/17/2023 70.19% 湖街 24 美元 → 37 美元 维护 购买
09/08/2022 -21.8% B. 莱利证券 → 17 美元 恢复 → 购买
05/20/2022 -8% B. 莱利证券 17 美元 → 20 美元 维护 购买
07/02/2021 -34.45% 拉登堡塔尔曼 → 14.25 美元 启动覆盖开启 → 购买
2020 年 7 月 4 日 -54% B. 莱利证券 12 美元 → 10 美元 维护 购买
03/16/2020 -44.8% B. 莱利证券 12.75 美元 → 12 美元 维护 购买

What is the target price for Harrow Health (HROW)?

Harrow Health(HROW)的目标价格是多少?

The latest price target for Harrow Health (NASDAQ: HROW) was reported by B. Riley Securities on July 20, 2023. The analyst firm set a price target for $45.00 expecting HROW to rise to within 12 months (a possible 106.99% upside). 3 analyst firms have reported ratings in the last year.

B. Riley Securities于2023年7月20日公布了哈罗健康(纳斯达克股票代码:HROW)的最新目标股价。这家分析公司将目标股价定为45.00美元,预计HROW将在12个月内升至106.99%(可能上涨106.99%)。去年有3家分析公司公布了评级。

What is the most recent analyst rating for Harrow Health (HROW)?

分析师对哈罗健康(HROW)的最新评级是多少?

The latest analyst rating for Harrow Health (NASDAQ: HROW) was provided by B. Riley Securities, and Harrow Health maintained their buy rating.

哈罗健康(纳斯达克股票代码:HROW)的最新分析师评级由B. Riley Securities提供,哈罗健康维持买入评级。

When is the next analyst rating going to be posted or updated for Harrow Health (HROW)?

Harrow Health(HROW)的下一个分析师评级何时公布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harrow Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harrow Health was filed on July 20, 2023 so you should expect the next rating to be made available sometime around July 20, 2024.

分析师在进行了广泛的研究(包括浏览公开财务报表、与Harrow Health的高管和客户交谈以及听取财报电话会议)后得出股票评级。大多数分析师每三个月进行一次评级,因此每家公司每年应该获得4个评级。Harrow Health 的最后一次评级是在2023年7月20日提交的,因此你应该预计下一个评级将在2024年7月20日左右公布。

Is the Analyst Rating Harrow Health (HROW) correct?

分析师对 Harrow Health (HROW) 的评级正确吗?

While ratings are subjective and will change, the latest Harrow Health (HROW) rating was a maintained with a price target of $42.00 to $45.00. The current price Harrow Health (HROW) is trading at is $21.74, which is out of the analyst's predicted range.

尽管评级是主观的,将会发生变化,但最新的Harrow Health(HROW)评级维持不变,目标股价为42.00美元至45.00美元。Harrow Health(HROW)目前的交易价格为21.74美元,超出了分析师的预测区间。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发